Literature DB >> 30060076

Combining common genetic variants and non-genetic risk factors to predict risk of cutaneous melanoma.

Fangyi Gu1,2, Ting-Huei Chen3, Ruth M Pfeiffer2, Maria Concetta Fargnoli4, Donato Calista5, Paola Ghiorzo6, Ketty Peris7, Susana Puig8, Chiara Menin9, Arcangela De Nicolo10, Monica Rodolfo11, Cristina Pellegrini4, Lorenza Pastorino6, Evangelos Evangelou12,13, Tongwu Zhang2, Xing Hua2, Curt T DellaValle2, D Timothy Bishop14, Stuart MacGregor15, Mark I Iles14, Matthew H Law15, Anne Cust16, Kevin M Brown2, Alexander J Stratigos17, Eduardo Nagore18, Stephen Chanock2, Jianxin Shi2, Melanoma Meta-Analysis Consortium, MelaNostrum Consortium, Maria Teresa Landi2.   

Abstract

Melanoma heritability is among the highest for cancer and single nucleotide polymorphisms (SNPs) contribute to it. To date, only SNPs that reached statistical significance in genome-wide association studies or few candidate SNPs have been included in melanoma risk prediction models. We compared four approaches for building polygenic risk scores (PRS) using 12 874 melanoma cases and 23 203 controls from Melanoma Meta-Analysis Consortium as a training set, and newly genotyped 3102 cases and 2301 controls from the MelaNostrum consortium for validation. We estimated adjusted odds ratios (ORs) for melanoma risk using traditional melanoma risk factors and the PRS with the largest area under the receiver operator characteristics curve (AUC). We estimated absolute risks combining the PRS and other risk factors, with age- and sex-specific melanoma incidence and competing mortality rates from Italy as an example. The best PRS, including 204 SNPs (AUC = 64.4%; 95% confidence interval (CI) = 63-65.8%), developed using winner's curse estimate corrections, had a per-quintile OR = 1.35 (95% CI = 1.30-1.41), corresponding to a 3.33-fold increase comparing the 5th to the 1st PRS quintile. The AUC improvement by adding the PRS was up to 7%, depending on adjusted factors and country. The 20-year absolute risk estimates based on the PRS, nevus count and pigmentation characteristics for a 60-year-old Italian man ranged from 0.5 to 11.8% (relative risk  = 26.34), indicating good separation.

Entities:  

Mesh:

Year:  2018        PMID: 30060076      PMCID: PMC6240742          DOI: 10.1093/hmg/ddy282

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  50 in total

1.  Testing calibration of risk models at extremes of disease risk.

Authors:  Minsun Song; Peter Kraft; Amit D Joshi; Myrto Barrdahl; Nilanjan Chatterjee
Journal:  Biostatistics       Date:  2014-07-14       Impact factor: 5.899

2.  Prediction of Melanoma Risk in a Southern European Population Based on a Weighted Genetic Risk Score.

Authors:  Katerina P Kypreou; Irene Stefanaki; Kyriaki Antonopoulou; Fani Karagianni; Georgios Ntritsos; Alexios Zaras; Vasiliki Nikolaou; Iro Kalfa; Vasiliki Chasapi; Dorothea Polydorou; Helen Gogas; George M Spyrou; Lars Bertram; Christina M Lill; John P A Ioannidis; Christina Antoniou; Evangelos Evangelou; Alexander I Stratigos
Journal:  J Invest Dermatol       Date:  2015-12-14       Impact factor: 8.551

3.  Development of a targeted risk-group model for skin cancer screening based on more than 100,000 total skin examinations.

Authors:  S Guther; K Ramrath; D Dyall-Smith; M Landthaler; W Stolz
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-03-04       Impact factor: 6.166

4.  IRF4 variants have age-specific effects on nevus count and predispose to melanoma.

Authors:  David L Duffy; Mark M Iles; Dan Glass; Gu Zhu; Jennifer H Barrett; Veronica Höiom; Zhen Z Zhao; Richard A Sturm; Nicole Soranzo; Chris Hammond; Marina Kvaskoff; David C Whiteman; Massimo Mangino; Johan Hansson; Julia A Newton-Bishop; Veronique Bataille; Nicholas K Hayward; Nicholas G Martin; D Timothy Bishop; Timothy D Spector; Grant W Montgomery
Journal:  Am J Hum Genet       Date:  2010-06-17       Impact factor: 11.025

5.  Development of an individual score for melanoma risk.

Authors:  Gaelle Quéreux; Dominique Moyse; Yves Lequeux; Olivier Jumbou; Anabelle Brocard; Daniel Antonioli; Brigitte Dréno; Jean-Michel Nguyen
Journal:  Eur J Cancer Prev       Date:  2011-05       Impact factor: 2.497

6.  Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Authors:  Jedd D Wolchok; Vanna Chiarion-Sileni; Rene Gonzalez; Piotr Rutkowski; Jean-Jacques Grob; C Lance Cowey; Christopher D Lao; John Wagstaff; Dirk Schadendorf; Pier F Ferrucci; Michael Smylie; Reinhard Dummer; Andrew Hill; David Hogg; John Haanen; Matteo S Carlino; Oliver Bechter; Michele Maio; Ivan Marquez-Rodas; Massimo Guidoboni; Grant McArthur; Celeste Lebbé; Paolo A Ascierto; Georgina V Long; Jonathan Cebon; Jeffrey Sosman; Michael A Postow; Margaret K Callahan; Dana Walker; Linda Rollin; Rafia Bhore; F Stephen Hodi; James Larkin
Journal:  N Engl J Med       Date:  2017-09-11       Impact factor: 91.245

7.  Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.

Authors:  Jeffrey E Gershenwald; Richard A Scolyer; Kenneth R Hess; Vernon K Sondak; Georgina V Long; Merrick I Ross; Alexander J Lazar; Mark B Faries; John M Kirkwood; Grant A McArthur; Lauren E Haydu; Alexander M M Eggermont; Keith T Flaherty; Charles M Balch; John F Thompson
Journal:  CA Cancer J Clin       Date:  2017-10-13       Impact factor: 508.702

8.  Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-up.

Authors:  Fan Liu; Mijke Visser; David L Duffy; Pirro G Hysi; Leonie C Jacobs; Oscar Lao; Kaiyin Zhong; Susan Walsh; Lakshmi Chaitanya; Andreas Wollstein; Gu Zhu; Grant W Montgomery; Anjali K Henders; Massimo Mangino; Daniel Glass; Veronique Bataille; Richard A Sturm; Fernando Rivadeneira; Albert Hofman; Wilfred F J van IJcken; André G Uitterlinden; Robert-Jan T S Palstra; Timothy D Spector; Nicholas G Martin; Tamar E C Nijsten; Manfred Kayser
Journal:  Hum Genet       Date:  2015-05-12       Impact factor: 4.132

9.  Prediction of breast cancer risk based on profiling with common genetic variants.

Authors:  Nasim Mavaddat; Paul D P Pharoah; Kyriaki Michailidou; Jonathan Tyrer; Mark N Brook; Manjeet K Bolla; Qin Wang; Joe Dennis; Alison M Dunning; Mitul Shah; Robert Luben; Judith Brown; Stig E Bojesen; Børge G Nordestgaard; Sune F Nielsen; Henrik Flyger; Kamila Czene; Hatef Darabi; Mikael Eriksson; Julian Peto; Isabel Dos-Santos-Silva; Frank Dudbridge; Nichola Johnson; Marjanka K Schmidt; Annegien Broeks; Senno Verhoef; Emiel J Rutgers; Anthony Swerdlow; Alan Ashworth; Nick Orr; Minouk J Schoemaker; Jonine Figueroa; Stephen J Chanock; Louise Brinton; Jolanta Lissowska; Fergus J Couch; Janet E Olson; Celine Vachon; Vernon S Pankratz; Diether Lambrechts; Hans Wildiers; Chantal Van Ongeval; Erik van Limbergen; Vessela Kristensen; Grethe Grenaker Alnæs; Silje Nord; Anne-Lise Borresen-Dale; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Jenny Chang-Claude; Anja Rudolph; Petra Seibold; Dieter Flesch-Janys; Peter A Fasching; Lothar Haeberle; Arif B Ekici; Matthias W Beckmann; Barbara Burwinkel; Frederik Marme; Andreas Schneeweiss; Christof Sohn; Amy Trentham-Dietz; Polly Newcomb; Linda Titus; Kathleen M Egan; David J Hunter; Sara Lindstrom; Rulla M Tamimi; Peter Kraft; Nazneen Rahman; Clare Turnbull; Anthony Renwick; Sheila Seal; Jingmei Li; Jianjun Liu; Keith Humphreys; Javier Benitez; M Pilar Zamora; Jose Ignacio Arias Perez; Primitiva Menéndez; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska-Bieniek; Katarzyna Durda; Natalia V Bogdanova; Natalia N Antonenkova; Thilo Dörk; Hoda Anton-Culver; Susan L Neuhausen; Argyrios Ziogas; Leslie Bernstein; Peter Devilee; Robert A E M Tollenaar; Caroline Seynaeve; Christi J van Asperen; Angela Cox; Simon S Cross; Malcolm W R Reed; Elza Khusnutdinova; Marina Bermisheva; Darya Prokofyeva; Zalina Takhirova; Alfons Meindl; Rita K Schmutzler; Christian Sutter; Rongxi Yang; Peter Schürmann; Michael Bremer; Hans Christiansen; Tjoung-Won Park-Simon; Peter Hillemanns; Pascal Guénel; Thérèse Truong; Florence Menegaux; Marie Sanchez; Paolo Radice; Paolo Peterlongo; Siranoush Manoukian; Valeria Pensotti; John L Hopper; Helen Tsimiklis; Carmel Apicella; Melissa C Southey; Hiltrud Brauch; Thomas Brüning; Yon-Dschun Ko; Alice J Sigurdson; Michele M Doody; Ute Hamann; Diana Torres; Hans-Ulrich Ulmer; Asta Försti; Elinor J Sawyer; Ian Tomlinson; Michael J Kerin; Nicola Miller; Irene L Andrulis; Julia A Knight; Gord Glendon; Anna Marie Mulligan; Georgia Chenevix-Trench; Rosemary Balleine; Graham G Giles; Roger L Milne; Catriona McLean; Annika Lindblom; Sara Margolin; Christopher A Haiman; Brian E Henderson; Fredrick Schumacher; Loic Le Marchand; Ursula Eilber; Shan Wang-Gohrke; Maartje J Hooning; Antoinette Hollestelle; Ans M W van den Ouweland; Linetta B Koppert; Jane Carpenter; Christine Clarke; Rodney Scott; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Hermann Brenner; Volker Arndt; Christa Stegmaier; Aida Karina Dieffenbach; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Kenneth Offit; Joseph Vijai; Mark Robson; Rohini Rau-Murthy; Miriam Dwek; Ruth Swann; Katherine Annie Perkins; Mark S Goldberg; France Labrèche; Martine Dumont; Diana M Eccles; William J Tapper; Sajjad Rafiq; Esther M John; Alice S Whittemore; Susan Slager; Drakoulis Yannoukakos; Amanda E Toland; Song Yao; Wei Zheng; Sandra L Halverson; Anna González-Neira; Guillermo Pita; M Rosario Alonso; Nuria Álvarez; Daniel Herrero; Daniel C Tessier; Daniel Vincent; Francois Bacot; Craig Luccarini; Caroline Baynes; Shahana Ahmed; Mel Maranian; Catherine S Healey; Jacques Simard; Per Hall; Douglas F Easton; Montserrat Garcia-Closas
Journal:  J Natl Cancer Inst       Date:  2015-04-08       Impact factor: 13.506

10.  Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

Authors:  Lauren G Aoude; Antonia L Pritchard; Carla Daniela Robles-Espinoza; Karin Wadt; Mark Harland; Jiyeon Choi; Michael Gartside; Víctor Quesada; Peter Johansson; Jane M Palmer; Andrew J Ramsay; Xijun Zhang; Kristine Jones; Judith Symmons; Elizabeth A Holland; Helen Schmid; Vanessa Bonazzi; Susan Woods; Ken Dutton-Regester; Mitchell S Stark; Helen Snowden; Remco van Doorn; Grant W Montgomery; Nicholas G Martin; Thomas M Keane; Carlos López-Otín; Anne-Marie Gerdes; Håkan Olsson; Christian Ingvar; Ake Borg; Nelleke A Gruis; Jeffrey M Trent; Göran Jönsson; D Timothy Bishop; Graham J Mann; Julia A Newton-Bishop; Kevin M Brown; David J Adams; Nicholas K Hayward
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

View more
  14 in total

Review 1.  Progress report on the major clinical advances in patient-oriented research into familial melanoma (2013-2018).

Authors:  Mijke Visser; Nienke van der Stoep; Nelleke Gruis
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

Review 2.  Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?

Authors:  M R Roberts; M M Asgari; A E Toland
Journal:  Br J Dermatol       Date:  2019-07-07       Impact factor: 9.302

3.  A penalized regression framework for building polygenic risk models based on summary statistics from genome-wide association studies and incorporating external information.

Authors:  Ting-Huei Chen; Nilanjan Chatterjee; Maria Teresa Landi; Jianxin Shi
Journal:  J Am Stat Assoc       Date:  2020-10-12       Impact factor: 5.033

4.  Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies.

Authors:  Isabelle Kaiser; Sonja Mathes; Annette B Pfahlberg; Wolfgang Uter; Carola Berking; Markus V Heppt; Theresa Steeb; Katharina Diehl; Olaf Gefeller
Journal:  Cancers (Basel)       Date:  2022-06-20       Impact factor: 6.575

5.  Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals.

Authors:  Andrew Bakshi; Mabel Yan; Moeen Riaz; Galina Polekhina; Suzanne G Orchard; Jane Tiller; Rory Wolfe; Amit Joshi; Yin Cao; Aideen M McInerney-Leo; Tatiane Yanes; Monika Janda; H Peter Soyer; Anne E Cust; Matthew H Law; Peter Gibbs; Catriona McLean; Andrew T Chan; John J McNeil; Victoria J Mar; Paul Lacaze
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 11.816

6.  Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1.

Authors:  Lorenza Pastorino; Virginia Andreotti; Bruna Dalmasso; Irene Vanni; Giulia Ciccarese; Mario Mandalà; Giuseppe Spadola; Maria Antonietta Pizzichetta; Giovanni Ponti; Maria Grazia Tibiletti; Elena Sala; Maurizio Genuardi; Pietro Chiurazzi; Gabriele Maccanti; Siranoush Manoukian; Serena Sestini; Rita Danesi; Valentina Zampiga; Roberta La Starza; Ignazio Stanganelli; Alberto Ballestrero; Luca Mastracci; Federica Grillo; Stefania Sciallero; Federica Cecchi; Enrica Teresa Tanda; Francesco Spagnolo; Paola Queirolo; Alisa M Goldstein; William Bruno; Paola Ghiorzo
Journal:  Cancers (Basel)       Date:  2020-04-19       Impact factor: 6.639

7.  Contribution of Common Genetic Variants to Familial Aggregation of Disease and Implications for Sequencing Studies.

Authors:  Andrew Schlafly; Ruth M Pfeiffer; Eduardo Nagore; Susana Puig; Donato Calista; Paola Ghiorzo; Chiara Menin; Maria Concetta Fargnoli; Ketty Peris; Lei Song; Tongwu Zhang; Jianxin Shi; Maria Teresa Landi; Joshua Neil Sampson
Journal:  PLoS Genet       Date:  2019-11-15       Impact factor: 5.917

8.  Interleukin 1 receptor antagonist gene variable number of tandem repeats polymorphism and cutaneous melanoma.

Authors:  Sabina Cauci; Cinzia Buligan; Francesco Rocchi; Ilaria Salvador; Luigi Xodo; Giuseppe Stinco
Journal:  Oncol Lett       Date:  2019-09-25       Impact factor: 2.967

9.  Risk Prediction Models for Melanoma: A Systematic Review on the Heterogeneity in Model Development and Validation.

Authors:  Isabelle Kaiser; Annette B Pfahlberg; Wolfgang Uter; Markus V Heppt; Marit B Veierød; Olaf Gefeller
Journal:  Int J Environ Res Public Health       Date:  2020-10-28       Impact factor: 3.390

10.  Sortilin as a Biomarker for Cardiovascular Disease Revisited.

Authors:  Peter Loof Møller; Palle D Rohde; Simon Winther; Peter Breining; Louise Nissen; Anders Nykjaer; Morten Bøttcher; Mette Nyegaard; Mads Kjolby
Journal:  Front Cardiovasc Med       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.